We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App

QIAGEN Demonstrates Its Revolutionary Molecular Diagnostic Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: QIAGEN is participating in Medlab Middle East 2023 (Photo courtesy of QIAGEN)
Image: QIAGEN is participating in Medlab Middle East 2023 (Photo courtesy of QIAGEN)

QIAGEN N.V. (Venlo, Netherlands) is demonstrating its revolutionary NeuMoDx molecular systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

The NeuMoDx molecular systems provide the industry’s first true continuous random-access solution and are scalable to meet the needs of the modern clinical laboratory. The NeuMoDx 96 and NeuMoDx 288 Molecular Systems are fully automated analyzers that use proprietary NeuDry technology, magnetic particle affinity capture, and real-time PCR chemistry in a multi-sample microfluidic cartridge. This unique integration of robotics with advanced microfluidics delivers industry-leading usability, enhanced performance, increased efficiency, and rapid turnaround.

QIAGEN is also highlighting its QIAstat-Dx multiplex syndromic testing solution that simplifies infectious disease diagnostics to help healthcare professions generate faster results for their patients. All that is needed are a patient sample, a QIAstat-Dx assay cartridge and the intuitive QIAstat-Dx instrument. QIAGEN is providing a glimpse of its upcoming QIAstat-Dx Rise, its higher capacity syndromic testing platform that will offer comprehensive pathogen coverage using the same trusted technology as the QIAstat-Dx Analyzer, tailored for high demand institutions.

Also featuring at the show is the innovative Rotor-Gene Q MDx instrument that enables high-precision real-time PCR. In combination with QIAGEN CE-IVD-marked PCR kits, the Rotor-Gene Q MDx instrument is highly suited for in vitro diagnostic applications. QIAGEN is showcasing the QIAcube Connect MDx that brings automated IVD sample processing for DNA/RNA purification within the reach of laboratories alongside the QIAsymphony SP/AS System that purifies DNA, RNA and bacterial and viral nucleic acids from a wide range of starting materials.

Among its solutions for quick and efficient routine as well as pandemic testing, QIAGEN is presenting the PAXgene Blood ccfDNA Tubes (CE-IVD) that simplify the collection and processing of whole blood for subsequent purification of circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction. Using PAXgene Blood ccfDNA Tubes (CE-IVD) for whole blood collection, storage and transport helps prevent the release of intracellular DNA into plasma. QIAGEN is also demonstrating the PAXgene Saliva Collector which is a non-invasive sample collection device for human saliva collection, stabilization, transport and storage. Designed to simplify at-home collection without the intervention of lab personnel, the collection device contains a stabilizing solution which maintains the DNA levels in human saliva samples by protecting DNA from degradation and inhibiting bacterial growth over storage time. Additionally, QIAGEN is showcasing the QuantiFERON-TB Gold (QFT) blood test that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB).

Related Links:

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.